Gene Query: MMAB

Dataset Description Geneva Score
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 47.19
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 28.77
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 21.61
RNAseq Analysis in glioblastoma cells treated with Mepazine 18.17
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 17.96
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 17.96
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 17.0
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 16.79
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 16.63
MARS Seq data from human cortical organoids 16.02
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 15.55
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 15.46
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 14.98
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 14.87
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 14.86
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 14.76
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 14.09
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 13.82
Chromatin landscape of human visceral and subcutaneous adipocytes 13.49
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 13.33
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 13.32
Hijacking of stress response machinery by oncogenes in acute leukaemia 13.2
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 13.2
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 13.04
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 13.03
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 12.88
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 12.82
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 12.56
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 12.52
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 12.46
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 12.32
Cellular response to hepatitis E virus (HEV) infection 12.09
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 11.77
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 11.71
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 11.69
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 11.62
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 11.57
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 11.57
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 11.27
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 11.27
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 11.25
Hepatitis C virus functionally sequesters miR-122 11.25
Role for citron kinase in prostate cancer growth 11.21
RNA-Seq from early time points in the kidney differentiation protocol 10.96
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 10.6
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 10.59
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 10.5
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 10.5
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 10.48
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 10.43
Tracking of dCas9-methyltransferase footprints 10.37
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 10.33
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 10.14
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 10.13
Nutritional control of protein translation 9.97
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 9.68
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 9.52
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 9.44
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 9.41
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 9.4
Regulatory network controlling tumor-promoting inflammation in human cancers 9.4
Effect of PRDM11 depletion in U2932 cells 9.32
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 9.31
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 9.31
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 9.16
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 9.15
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 9.13
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 9.11
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 9.11
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 9.05
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 9.04
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 9.04
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 9.04
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 9.02
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 8.96
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 8.94
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 8.93
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 8.92
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 8.89
Genome-wide functional assessment of enhancer activities in the human genome 8.83
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 8.82
N6-methyladenine DNA Modification in Glioblastoma 8.82
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 8.81
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 8.81
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 8.54
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 8.5
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 8.49
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 8.4
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 8.15
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 7.95
RNA Seq of Alagille liver biopsies 7.93
Alagille_Nodder 7.93
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 7.91
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 7.85
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 7.84
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 7.77
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 7.76
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 7.76
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 7.7
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 7.67
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 7.66
scRNASeq analysis of cycling cardiomyocytes 7.65
Paxillin regulates genomic networks in prostate cancer [LNCaP] 7.62
Generating Patterned Kidney Organoids for Studying Development and Diseases 7.62
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 7.61
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 7.61
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 7.48
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 7.46
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 7.46
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 7.43
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 7.43
Differential responses of human fetal brain neural stem cells to Zika virus infection 7.29
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 7.25
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 7.24
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 7.23
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 7.23
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 7.18
Role of FGFR1 in neuronal devlopment 7.11
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 7.01
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 6.97
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 6.94
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 6.94
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 6.93
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 6.92
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 6.89
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 6.89
RNA-sequencing of human liver tissue 6.89
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 6.83
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 6.79
Developmental stage specific chromosome architecture in human erythroid cells 6.79
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 6.77
Trans-differentiation of human adult peripheral blood T cells into neurons 6.66
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 6.65
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 6.65
Downregulation of DDX5/DDX17 and REST 6.61
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 6.59
TGF-β promotes genomic instability after loss of RUNX3 6.56
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 6.55
Comprehensive comparative analysis of 5’ end RNA sequencing methods 6.51
KSDM1b Role in Ewing Sarcoma 6.46
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 6.42
RNA seq with AML (NB4) cells upon FTO inhibition 6.42
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 6.38
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 6.38
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 6.34
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 6.33
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 6.31
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 6.3
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 6.26
Paxillin regulates genomic networks in prostate cancer [C4-2] 6.23
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 6.21
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 6.2
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 6.18
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 6.09
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 6.01
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 6.0
Energy Metabolism during Anchorage-Independence 5.99
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 5.97
HNF1A deficiency impairs β-cell fate, granule maturation and function 5.96
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 5.91
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 5.91
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 5.89
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 5.88
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 5.87
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 5.85
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 5.84
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 5.84
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 5.82
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 5.82
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 5.76
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 5.72
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 5.72
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 5.72
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 5.7
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 5.7
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 5.68
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 5.66
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 5.66
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 5.65
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 5.64
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 5.63
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 5.59
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 5.59
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 5.57
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 5.57
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 5.57
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 5.57
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 5.55
Selective expression of long non-coding RNAs in a breast cancer cell progression model 5.53
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 5.51
An RNA-centric dissection of host complexes controlling flavivirus infection 5.5
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 5.5
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 5.47
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 5.44
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 5.44
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 5.42
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 5.42
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 5.41
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 5.41
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 5.4
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  5.38
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 5.36
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 5.33
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 5.33
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 5.29
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 5.29
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 5.21
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 5.21
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 5.16
Evaluating pre-clinical models for studying NASH driven HCC. 5.15
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 5.15
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 5.15
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 5.14
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 5.11
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 5.1
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 5.08
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 5.07
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 5.07
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 5.07
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 5.01
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 4.98
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 4.94
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 4.92
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 4.92
Argonaute proteins couple chromatin silencing to alternative splicing 4.89
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 4.89
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 4.88
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 4.86
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 4.85
4.82
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 4.81
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 4.81
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 4.8
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 4.8
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 4.78
Genome wide expression change in LCC2 and MCF-7 cells 4.78
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 4.73
hnRNP C is a key regulator of protein synthesis in mitosis 4.72
Gene expression changes upon drug withdrawal (Mel888 cell line) 4.72
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 4.71
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 4.7
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 4.62
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 4.6
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 4.59
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 4.59
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 4.59
Global analysis of enhancer targets: Mosaic-seq 4.56
A single cell reference map for human blood and tissue T cell activation 4.54
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 4.54
CROP-Seq in Primary Human T Cells 4.5
Effect of CHKA knockdown on C4-2 cell transcriptome 4.46
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 4.45
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 4.34
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 4.3
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 4.29
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 4.29
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 4.27
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 4.25
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 4.25
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 4.18
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 4.15
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 4.13
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 4.09
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 4.09
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 4.01
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 3.98
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 3.97
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 3.95
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 3.93
RNA-seq of cancer cell lines treated with T-025 3.91
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 3.9
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 3.9
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 3.89
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 3.89
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 3.86
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 3.86
RNA-seq analysis of differentiating human erythroblasts 3.85
Profile of gene expression in U87-MG xenografts expressing control vector (V0), the ubiquitin ligase KPC1 or the p50 subunit of the NF-kB transcription factor, using RNASeq analysis of transcripts mapped independently to the human and murine genomes 3.84
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 3.8
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 3.8
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 3.8
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 3.8
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 3.79
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 3.79
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 3.79
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 3.77
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 3.72
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 3.69
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 3.64
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 3.62
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 3.58
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 3.58
Transcriptome landscape of HeLa response upon triamcinolone acetonide 3.53
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 3.53
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 3.51
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 3.51
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 3.51
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 3.49
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 3.48
Controlling for gene expression changes in transcription factor protein networks. 3.48
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 3.44
An integrative analysis of non-coding regulatory DNA variations associated with autism 3.4
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 3.4
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 3.39
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 3.34
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 3.33
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 3.32
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 3.28
HNRNPM-regulated splicing dependencies in prostate cancer 3.28
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 3.27
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 3.21
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 3.16
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 3.11
Human ovarian granulosa cell transcriptome 3.05
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 3.03
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 3.03
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 3.02
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 2.97
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 2.97
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 2.95
Loss of CREBBP results in gene expression repression in lymphoma cells 2.95
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 2.95
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 2.89
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 2.86
Identification of HOXB13 target genes responsive to BET inhibitors 2.84
Gene expression profile in breast cancer cell lines using RNA sequencing 2.84
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 2.82
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 2.81
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 2.8
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 2.72
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 2.72
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 2.71
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 2.71
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 2.67
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 2.59
Primary Human B-cell Temporal Response to CD40L Stimulation 2.58
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 2.55
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 2.5
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 2.47
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 2.44
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 2.43
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 2.4
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 2.38
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 2.37
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 2.37
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 2.37
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 2.36
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 2.32
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 2.21
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 2.21
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 2.19
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 2.18
Zone dependent distinctive gene expression profile of the normal human liver tissue 2.17
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 2.17
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 2.15
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 2.12
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 2.11
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 2.11
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 2.09
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 2.06
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 2.06
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 2.04
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 2.04
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 2.04
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 2.04
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 2.04
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 2.0
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 1.96
NR2F2 study 1.95
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 1.95
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 1.94
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 1.86
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 1.84
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 1.82
RNA-sequencing of healthy human skeletal myocytes 1.81
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 1.81
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 1.8
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 1.79
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 1.78
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 1.77
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 1.72
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 1.67
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 1.67
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 1.67
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 1.57
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 1.57
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 1.57
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 1.56
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 1.56
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 1.46
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 1.45
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 1.44
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 1.44
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 1.43
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 1.42
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 1.39
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 1.39
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 1.34
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 1.31
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.26
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 1.24
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 1.23
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits 1.22
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 1.2
Functional significance of the HIV-1 Tat signature amino acid residues 1.18
CDK4/6 inhibitor resistance in prostate cancer 1.15
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.14
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 1.13
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 1.07
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 1.07
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 1.04
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 1.04
miRNAs affected by antagomiR-17 treatment 1.03
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 1.03
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 1.0
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 1.0
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 0.99
Hepatocyte maturation 0.98
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 0.98
RNAseq of cell lines with knocked in ESR1 mutations 0.96
Targeting MTHFD2 in Acute Myeloid Leukemia 0.96
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.96
RNA editing in nascent RNA affects pre-mRNA splicing 0.96
Effect of FGF13 depletion on the H460 cell line 0.95
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 0.95
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 0.95
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 0.94
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.92
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 0.91
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 0.9
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 0.87
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.86
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 0.86
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 0.83
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 0.82
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 0.79
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 0.79
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 0.76
Oncogenic roles of ARID5B in T-ALL 0.76
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.76
Regulation of hypoxia-inducible factor activity by ZMYND8 0.73
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 0.64
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 0.63
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 0.62
Effects of transcription on genome - nuclear lamina interactions 0.62
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.61
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.61
Function and hormonal regulation of GATA3 in human first trimester placentation 0.58
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 0.57
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.57
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 0.53
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 0.49
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 0.48
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 0.48
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 0.48
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.48
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 0.41
hNSCs siRNA NOVA2 0.4
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.39
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.39
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.39
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.39
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.38
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.35
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.35
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 0.35
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.34
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 0.31
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 0.31
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.3
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.29
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.28
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 0.26
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 0.25
Interphase condensins regulate ligand-depedent enhancer activation 0.21
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.21
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 0.21
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 0.21
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.21
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.2
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 0.2
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 0.15
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 0.13
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 0.13
Genome-wide analysis of the Integrator complex 0.12
Genome-wide analysis of the Integrator complex (HTS) 0.12
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 0.12
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 0.1
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 0.1
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 0.09
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.09
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.08
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 0.07
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.06
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 0.03
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.03
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 0.02
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 0.02
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.01
RNA-Seq and expression data from human adipose tissue 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation